4.7 Review

Cross-priming in health and disease

Journal

NATURE REVIEWS IMMUNOLOGY
Volume 10, Issue 6, Pages 403-414

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nri2780

Keywords

-

Categories

Funding

  1. German Research foundation
  2. German Academic Exchange service (DAAD)
  3. Group of Eight, Australia

Ask authors/readers for more resources

Cross-priming is an important mechanism to activate cytotoxic T lymphocytes (CTLs) for immune defence against viruses and tumours. Although it was discovered more than 25 years ago, we have only recently gained insight into the underlying cellular and molecular mechanisms, and we are just beginning to understand its physiological importance in health and disease. Here we summarize current concepts on the cross-talk between the immune cells involved in CTL cross-priming and on its role in antimicrobial and antitumour defence, as well as in immune-mediated diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available